1-ethyl-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine hydrochloride, 95.0%, 1g

tert-Butyl (6S,8aR)-6-(hydroxymethyl)hexahydropyrrolo[1,2-a]pyrazine-2(1H)-carboxylate, 97%, 100mg

N-[(1S,2S)-2-Amino-1,2-diphenylethyl]-1,1,1-trifluoromethanesulfonamide, 97%, 25g

2-BROMO-5-CHLORO-1,3-THIAZOLE-4-CARBONITRILE, 95%, 1g

1,2,3,5,6,7-Hexahydro-s-indacen-4-amine, 98.0%, 250mg

7-Bromo-2-methylimidazo[1,2-a]-pyridine-3-carboxylic acid, 97%, 100mg

3-HYDROXY-2-METHOXYBENZONITRILE, 97.0%, 1g

Methyl 5,6-Dichloronicotinate, 97.0%, 1g

Volumetric pipettes 1 marking, class AS, 10 ml, 6 pieces

(S)-2-((tert-Butoxycarbonyl)amino)-3-(1H-pyrrolo[2,3-b]pyridin-3-yl)propanoic acid, 95%, 1g

TENAPANOR, 95%, 50mg

3-(2-methylpropyl)-1,2-oxazol-5-amine, 95.0%, 250mg

2-Methoxy-6-vinylnaphthalene, 95.0%, 1g